





































dilateral Sequential Lung Transplantation


































aung transplantation has become a viable and effective
treatment for patients with end-stage lung disease and
as been performed in more than 25,000 recipients world-
ide. Much progress has beenmade in surgical techniques of
ung transplantation, donor lung preservation, lung reperfu-
ion protocols, perioperative care, and long-term medical
anagement of lung transplant recipients since the initial
eport of human lung transplantation by Dr. James Hardy in
9631 and the first successful transplants by Dr. Joel Cooper
t the University of Toronto in 1983.2 These improvements
n care are associated with improvements in patient survival.
ne-year survival reported by the Organ Procurement and
ransplantation Network has improved from 74% in 1994 to
4% in 2004. Our experience at the Duke University Lung
ransplant Program is similar to that with the most recent
-year cohort of patients experiencing 30-day, 1-year, and
-year survivals of 98, 92, and 81%, respectively. Death early
fter transplant is commonly related to primary graft dys-
unction (PGD) that is usually caused by ischemia-reperfu-
ion injury. PGD rates have substantially decreased with bet-
er lung preservation and controlled reperfusion strategies.
arly posttransplant recipient survival, as well as lung allo-
raft survival, now approximates that seen with other solid
rgan transplants; however, longer term survival continues
o be suboptimal, with 5- and 10- year survival in registry
ata of 45 and 25%, respectively. Late deaths are most fre-
uently related to chronic allograft dysfunction, the causes of
hich are related to both immunologic and nonimmunologic
actors. The control of these factors with better immunosup-
ressive regimens and with minimizing nonimmunologic in-
ury such as with the use of surgical fundoplication to limit
astroesophageal reflux-related aspiration into the tracheo-
ronchial tree appears to be improving long-term survival.
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oi:10.1053/j.optechstcvs.2007.03.001ndications for
ung Transplantation
ung transplantation has been successfully applied as a treat-
ent for patients with lung failure resulting from a wide
ange of lung diseases. Although specific listing criteria and
ndications have been widely reported, lung transplantation
s typically performed in the following: (1) patients with a
imited life expectancy secondary to lung failure, estimated to
e 6 to 12 months; (2) patients with the capability of tolerat-
ng and following the complicated posttransplant medical
egimen; and (3) patients without comorbidities that would
ignificantly impact posttransplant survival and quality of
ife, such as concurrent/recent malignancy, extra-thoracic in-
ection, or significant other organ dysfunction/failure. In se-
ect patients, concomitant other organ transplant or repara-
ive cardiac procedures can be performed with acceptable
esults.3
The choice to perform a single versus a bilateral, sequential
ung transplant is dependent on recipient characteristics and
alancing the value of increasing the number of recipients
ransplanted by performing two single-lung transplants from
single donor, with the benefit of improved long-term sur-
ival, as seen in bilateral lung transplants. The majority of
atients with nonseptic lung disease, such as chronic ob-
tructive pulmonary disorders, idiopathic pulmonary fibro-
is, and primary pulmonary hypertension, can safely un-
ergo single-lung transplant. Patients with septic lung
isease, such as bronchiectasis from either cystic fibrosis
CF) or non-CF, require bilateral lung transplantation to pre-
ent infectious complications emanating from the residual
ative lung. However, we have programmatically changed to
erforming only bilateral lung transplants since 2000 be-
ause of the numerous complications arising from the native
ung such as infection, hyperinflation of emphysematous
ung, malignancy, and most importantly, because of a 25%
bsolute difference in long-term survival between double-
nd single-lung transplant recipients.4-6
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58 R.D. DavisOperative TechniquesFigure 1 Positioning of the patient and skin incision. (A)
anteriorly and abducted carefully, avoiding over-abduc
cushioned support as the arms are flexed slightly at the
catheter, pulmonary artery catheter, and transesophagea
line for patient monitoring purposes because of a high
through the use of a posteriorly placed warming device a
umbilicus. The chest is prepped to the edge of the bodyThe patient is placed in a supine position with both arms lifted
tion and potential stretch injury. The forearms are rested on
level of the elbow. In all patients, monitoring includes arterial
l echocardiogram (TEE). We routinely place a femoral arterial
rate of radial artery line failures. The patient is kept warm
nd an anteriorly placed warming blanket positioned below the
laterally where the skin meets the sheet of the operating table.
Bilateral sequential lung transplantation 59Figure 1 (Continued) For a male patient (B), the trans-sternal bilateral anterior thoracotomy (“clamshell” incision) is
performed at the level of the fourth intercostal space. For a female patient, the skin incision is made at or below the
inframammary crease, and the chest is opened through the fourth intercostal space after a breast flap is developed and
retracted superiorly on each side (C). After ligating the internal mammary pedicles, we routinely divide the sternal
transversely. Although we have had a low incidence of sternal complications, other groups have reported more sternal
wound problems and preferentially perform the procedure without division of the sternum through separate bilateral
antero-lateral thoracotomies. Posterolateral thoracotomy through the fifth intercostal space can be used on either side
for single-lung transplantation or on both sides as an alternative to the “clamshell” incision. This may be particularly
useful in situations where extensive adhesions are expected, such as patients with mycetomas, previous lobectomy, or
retransplantation.
60 R.D. DavisFigure 2 Chest wall retractors are placed on each side; the overall exposure to both diseased lungs is appreciated. At this
point, it is important to divide the mediastinal pleura superiorly to the level of the mammary vein and inferiorly to the
level of the pericardium with cautery. Before widely opening the retractors, the intercostal muscles in the fourth
intercostal space are divided in the lateral and posterior direction to maximize the overall exposure with the clamshell
incision while preserving the overlying latissimus dorsi and serratus anterior laterally. Adhesions are routinely encoun-
tered and are particularly prevalent in patients with CF, previous pneumothoraces, or previous pulmonary resections.
Although most adhesions can be safely divided using electrocautery, dissection of mediastinal adhesions in the area of
the phrenic nerve should be done sharply and with great caution. Following lung reduction surgery or previous
lobectomies, adhesions to the mediastinum may be such that the phrenic nerve cannot be identified. In these circum-
stances, it is often prudent to divide the overlying lung tissue using a GIA stapler and to leave a small amount of residual
lung to prevent phrenic nerve injury. This usually is accomplished after all other aspects of the pneumonectomy have
been performed. Frequently, this is the most time-consuming portion of the operation.
Bilateral sequential lung transplantation 61Figure 3 In recipients with small chest cavities such as most patients with idiopathic pulmonary fibrosis, a figure-of-
eight traction suture (0-silk) is placed into the fibrous dome of the diaphragm, and this suture is brought out of the chest
using a crochet hook passed through a 14-gauge angio-catheter placed in the most infero-lateral aspect of the pleural
cavity. The diaphragm is retracted inferiorly while pulling down with the suture, and the suture is secured external to
the chest wall with a small clamp. To aid in the exposure of the left hilum, a heavy silk retraction stitch is placed
inferiorly on the pericardium, posterior to the phrenic nerve, and anterior to the inferior pulmonary vein. The silk
suture is passed through a heavy-duty Rummel tourniquet, fashioned from a red rubber Robinson catheter, thus
allowing the heart to be safely retracted upward and to the right to provide improved exposure during further dissection
of the hilar structures and implantation of the donor lung (B). Br  bronchus; IPV  inferior pulmonary vein; PA 
pulmonary artery; PN  phrenic nerve; SPV  superior pulmonary vein.
62 R.D. DavisFigure 4 Although most lung transplants can be performed safely and efficiently without the use of cardiopulmonary
bypass (CPB), CPB should be used whenever recipient hemodynamics, poor systemic perfusion, or technical factors
dictate. We use CPB on a planned basis for patients (1) with severe pulmonary hypertension; (2) requiring intracardiac
procedures such as atrial septic defect/ventral septic defect closure or valve repair; (3) with an airway too small to place
a double lumen tube; (4) who are large relative to the donor lung to avoid full cardiac output through a small vascular
bed; and (5) with fragile left atrial tissue or inadequate donor left atrial cuff that allows the anastomoses to be performed
without clamps using either cardioplegic arrest or fibrillatory arrest. Particularly for patients with pulmonary hyper-
tension and presumed passive hepatic congestion, the bypass circuit is primed with fresh frozen plasma to mitigate
peri-transplant coagulopathy. The use of heparin-coated Carmeda circuits is advocated by some groups to reduce
coagulation dysregulation. We routinely use such circuits when extracorporeal membrane oxygenation (ECMO) is
used. For right and bilateral lung transplants, cannulation is performed in the chest using the right atrial appendage for
placement of a 120° double-stage cannula for venous return and ascending aorta cannulation for arterial return. For left
lung transplants, femoral venous cannulation is performed with a long Bio-Medicus venous (15 to 19 French) for
venous return with descending aorta cannulation for arterial return. Femoral venous cannulationmay be difficult in the
decubitus position and in urgent situations venous return can be achieved by cannulating the left pulmonary artery,
allowing more time to achieve either femoral venous access. Alternatively, we have been able to access the right atrial
appendage following initiation of CPB. Although CPB can be performed at any point in the operation as needed, our
preference is to perform as much of the dissection including a pneumonectomy before initiating bypass. When CPB is
utilized, we perform both pneumonectomies and full mobilization of all bronchus, pulmonary arteries, and left atrial
cuffs before initiating any portion of the implant procedure. If right-sided distension occurs, the pulmonary artery on
the contralateral side from the side of the initial implantation can be vented or simply divided and drained into a sump
catheter placed into the pleural space.
Bilateral sequential lung transplantation 63Figure 5 For bilateral lung transplants, we routinely mobilize both hilar structures completely before initiating the
recipient pneumonectomy. Which pneumonectomy and subsequent implantation is done first is dependent on several
factors listed in the relative order of importance: (1) normal chest cavity size and configuration; (2) donor lung quality
(a donor lung with contusion, consolidation, procurement injury is done second); (3) worst native lung function (this
side should preferentially be done first); and (4) the greater technical difficulty usually related to the amount and extent
of adhesions but also exposure (left usually worse than right). The recipient pneumonectomy differs from conventional
pneumonectomies in that intrapericardial dissection is always done, division of the pulmonary artery is done at or
beyond the takeoff of the branch vessels, and the bronchus is divided immediately proximal to the upper lobe orifice.
We find that the use of the endo GIA stapler facilitates the ligation and division of the pulmonary arteries and the
pulmonary veins.
64 R.D. DavisFigure 5 (Continued)
Bilateral sequential lung transplantation 65Figure 6 After the lung is removed, the pericardium around the hilar structures is circumferentially incised. Develop-
ment of Waterson’s groove on the right side, division of attachments from the roof of the left atrium to the pulmonary
artery, and the posterior left atrial wall and pericardium facilitate subsequent left atrial clamp placement. The pulmo-
nary arteries are mobilized proximally. On the right side, this requires division of attachments anteriorly to the superior
vena cava. On the left side, attention is paramount to avoid recurrent laryngeal nerve injury. Particularly in the
antero-superior portion of the left pulmonary artery, the use of electrocautery is avoided. It is important to establish
hemostasis, especially in the posterior mediastinum before initiating lung implantation. Particularly in patients with CF
and sarcoidosis, bleeding from lymph nodes and large bronchiole arteries can be problematic.Wide extirpation of these
lymph node groups with clip ligation of the bronchial arteries and other source vessels provides excellent hemostasis,
improves exposure, and can assist in preventing vascular anastomotic complications. Beginning in the plane immedi-
ately posterior to the pericardium facilitates this dissection. The vagus nerve located posterior and lateral to the
right-sided lymph node group should be identified and protected. We place 2-0 silk sutures through the vessel staple
lines and through the anterior cartilaginous portion of the trachea to allow retraction of these vessels and the airway to
facilitate exposure and the subsequent anastomoses.
66 R.D. DavisFigure 7 Before performing the donor lung implantation, the postero-lateral closure sutures are placed using two
figure-of-eight stitches using a monofilament no. 1 suture. Similarly, the posterior pleural drains are placed. We prefer
to use one large bore chest tube that is removed usually within 24 hours of the procedure and one 24-French soft drain
which is left for longer pleural drainage. Heparin is administered through a central vein (100 units/kg) with a goal
activated clotting time of approximately 300 seconds.
Bilateral sequential lung transplantation 67Figure 8 There is little difference between the implantation of the left or right lung. Usually, the left lung implantation
is slightly more difficult when performing a bilateral lung transplant because the heart and left atrial appendage
impedes the exposure for the left atrial anastomosis. The anastomoses are usually performed by the surgeon on
the ipsilateral side. However, the anterior portion of the bronchial anastomosis is often more easily performed by the
contralateral-sided surgeon. The mainstem bronchus is cut with a scalpel just proximal to the takeoff of the upper lobe
bronchus. After the cartilaginous portion of the bronchus is divided with a blade, a retraction stitch is placed anteriorly
to secure control over the bronchus. The remainder of the bronchial wall (posterior, membranous portion) is then
divided sharply. Any secretions within the lumen are aspirated and proper placement of the endotracheal tube location
is confirmed. The pleural space, bronchus, and endotracheal lumen are irrigated with an antibiotic solution. After
aspirating the antibiotic solution, iced laparotomy sponges are placed posteriorly in the pleural cavity, and the donor
lung is orthotopically positioned in the pleural cavity. The recipient bronchus and donor bronchus are aligned, and the
bronchial anastomosis is performed with a 4-0 PDS suture in a running fashion. The posterior, membranous portion of
the bronchial anastomosis is performed first, starting from one corner of the membrano-cartilaginous junctions. The
anterior, cartilaginous portion of the bronchus is anastomosed similarly using the running technique. Because one
bronchus is usually larger than the other, most commonly the recipient, we use an intussusception technique by placing
a transition stitch from the outside of the smaller bronchus into the inside of the larger bronchus. The orientation of the
anatomy is preserved with membranous-to-membranous and cartilagenous-to-cartilagenous apposition with approx-
imately a one-ring intussusception. We interrogate each anastomosis after completion. The bronchial anastomosis is
evaluated for an air leak under water while the anesthesiologist manually inflates the donor lung with room air.
Historically, buttressing of the anastomosis with peribronchial tissue or pericardium was considered important; we
have found this not to be necessary in the last 400 lung transplants.
68 R.D. DavisFigure 9 We perform the pulmonary artery (PA) anastomosis next. The recipient PA is occluded proximally with a
Satinsky vascular clamp, and the staple line is trimmed away proximal to the trunk raphe. The donor PA is similarly
trimmed to an appropriate length. Care must be taken not to leave the donor or recipient PA too long to avoid kinking
after the anastomosis is made. The recipient PA and the donor PA are aligned in preparation for the anastomosis, which
is begun in one corner with a 6-0 Prolene in a running fashion. On the left side, identifying the anterior and apical lobar
branches of the donor facilitates proper alignment. Assessment of the PA anastomosis is done by placing a second
vascular clamp (eg, Harken II) distal to the anastomosis and subsequently removing the previously placed Satinsky
clamp from the recipient PA.
Bilateral sequential lung transplantation 69Figure 10 The left atrial anastomosis is aided by the previous mobilization of the left atrium by dividing the attachments
between the roof of the left atrium and the PA and by fully mobilizing the left atrium from the pericardium. Placement
of the left atrial clamp is assisted by retracting the stapled superior and inferior pulmonary vein stumps laterally with
Pennington clamps. A large Satinsky vascular clamp is placed on the body of the left atrium. The staple lines are excised
and the orifices of the superior pulmonary vein and inferior pulmonary vein are connected, creating a large, recipient
left atrial cuff. By placing a Pennington clamp on the anterior portion of the atrial cuff and retracting superiorly and
medially, exposure is greatly improved, particularly on the left side. Exposure for the left-sided anastomosis often
requires substantial retraction of the heart. This can be facilitated by retraction of the previously placed pericardial
stitch and by manual retraction. During this period, placement of the patient into Trendelenburg position and bolus
administration of inotropic agents may be necessary. Occasionally, widely opening the pericardium to allow the heart
to herniate anteriorly and to the rightmay be necessary to provide exposure and suitable hemodynamics. Rarely, the use
of cardiopulmonary bypass is appropriate to facilitate the exposure and anastomosis. This is particularly warranted if
the donor left atrium begins to tear or adequate exposure of the atrial intima cannot be achieved circumferentially. An
endothelial-to-endothelial anastomosis is created using a running suture of 5-0 Prolene with a concerted effort to
include the intimal layer and exclude the muscular tissue. Once the posterior portion of the anastomosis is completed,
intravenous bolus of methylprednisolone (500 mg) and mannitol (25 g) are given.
70 R.D. DavisFigure 11 The anterior portion of the anastomosis continues with a running suture, leaving the last few throws of the 5-0
Prolene suture loose. De-airing of the graft is accomplished by partially releasing the vascular clamp on the PA and then
fully removing the Satinsky clamp on the recipient left atrium to force out any residual air before tying the 5-0 Prolene.
Assessment for residual air is obtained using TEE. Occasionally, aortic venting through an 18-gauge needle is necessary.
Reperfusion is carefully controlled to minimize the risk of PDG. Controlled, low-pressure perfusion of the lung is
achieved by gradually releasing the PA clamp over 10 to 15 minutes. Ventilation with room air is initiated by hand and
then by mechanical ventilation. Pressure control mode of ventilation is preferred with 5 to 8 cm of positive end-
expiratory pressure, distending pressure of 16 to 22 cm, and minimal FiO2—preferably less than 30%. During this
reperfusion period, hemostasis of the donor lung tissue is achieved and the anterior 28-French pleural chest tube is
placed. At the time of full release of the pulmonary artery clamp, the pulmonary artery pressures should be normal. We
use nitric oxide and loop diuretics liberally to assist in normalizing the pulmonary artery pressures and facilitating a low
FiO2 environment.
In patients undergoing double-lung transplants without CPB, once appropriate hemodynamics and oxygenation are
confirmed after reperfusion of the first transplanted lung, the remaining native lung is removed. Implantation proceeds
in a similar fashion as the first lung. The performance of bilateral dissection and mobilization initially greatly reduces
the duration in which the entire systemic blood flow passes through only one transplanted lung, which also appears to
minimize the development of PGD.
When CPB is utilized, we perform both pneumonectomies and place the postero-lateral thoracotomy closure sutures
and pleural drains lungs first. Both lungs are implanted before reperfusion. The first lung that is implanted is packed
in ice slush during implantation of the second lung. Methylprednisolone (1 g) and mannitol (50 g) are administrated
before reperfusion. While the lungs are ventilated with room air, gradual reperfusion is initiated starting at 5 to 10 mm
Hg mean PA pressure and increasing by 5 mm Hg every 5 minutes until normal systemic pressures are achieved.
Reperfusion of the lungs with oxygenated, hypocarbic blood may be especially advantageous to maximize pulmonary
vascular recruitment and parenchymal recovery.
Bilateral sequential lung transplantation 71Figure 12 The antero-medial aspect of the clamshell opening is approximated with three sets of no. 5 wires with one
simple set in the midline of the sternum and a figure-of-eight through the sternum and with the lateral aspect placed
lateral to the mammary pedicle around the fourth and fifth ribs. The remainder of the clamshell opening is reapproxi-
mated with a series of no. 1 Maxon sutures in a figure-of-eight fashion. Because the posterolateral sutures have already
been placed, these sutures are anterior to the transplanted lung and are easily placed without requiring retraction or
deflation of the lung. A 19-French soft drain is placed into each of the axillary spaces and under the breast flaps in
women. The pectoral fascial layer, the subcutaneous layer, the subdermal layer, and the skin are then approximated.
Following a single-lung transplant, closure of the posterolateral thoracotomy is conventional with large-bore chest
tubes placed in the anterior and posterior pleural space.
Chest tubes are placed to suction except in circumstances in which the recipient pleural space is substantially larger
than the donor lung size. In these situations, chest tubes are left to water seal to prevent over-distension of the lung
allograft, stretch injury, and severe pulmonary graft dysfunction. This situation can be identified by marked differences
in tidal volumes between when the pleural tubes are on or off suction.
After dressings are applied, the double lumen endotracheal tube is removed and a large single lumen endotracheal
tube is placed. Fiber optic bronchoscopy is performed to (1) assess the adequacy of the anastomosis; (2) clear
secretions; (3) assess for the development of PGD as manifested by severe pulmonary edema; and (4) evaluate for


















































he marked improvement in early patient survival has been
chieved by reduction of the incidence of PGD from the
revious 15 to 20% to the current rate of 5%. However,
evelopment of severe PGD as demonstrated bymarked hyp-
xia, pulmonary edema, elevated pulmonary artery pres-
ures, and poor compliance requires immediate investigation
or reversible causes. Most importantly, anastomotic or me-
hanical causes, especially venous outflow problems, need to
e identified and corrected immediately. Interrogation of the
nastomoses includes visual inspection to assess for torsion
r kinking, TEE to assess for turbulent or absent pulmonary
ein flow, left atrial anastomotic quality and presence of in-
raluminal clot, and direct measurement of pressures across
he anastomosis. Cardiac etiologies can usually be identified
y TEE, including left-sided valvular abnormalities, left ven-
ricular failure, intracardiac shunts, and tamponade.We rou-
inely obtain a quantitative perfusion scan within the first
ours after the transplant, with lobar or greater perfusion
efects necessitating further assessment, most preferably by
perative exploration. Asymmetric pulmonary edema, cres-
ent-shaped airways on bronchoscopic evaluation, may be
ndicative of mechanical problems. PGD can be caused by
umoral lung injury from circulating antidonor antibodies.
reatment of PGD is largely supportive unless reversible eti-
logies can be identified.We have shifted to a strategy of early
nstitution of veno-venous (V-V) ECMO when recipients de-
elop severe pulmonary edema or require FiO2  60% toetter resuscitate the injured lung and to avoid further injury
econdary to high FiO2 and barotrauma.
Tremendous progress has occurred in lung transplantation
ver the last two decades. One-year patient and allograft
urvival now is comparable to those of liver and cardiac trans-
lantation. As with all solid organ transplantations, the short-
ge of available donor organs and the development of chronic
llograft injury are the primary limitations to a greater appli-
ability to the treatment of end-stage lung diseases. Fortu-
ately, there appears to be opportunities to increase the num-
er of suitable donor lungs available. By better understanding
he causes of lung allograft injury and on-going work toward
eveloping immunologic tolerance, improved long-term out-
ome is achievable.
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